Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | RVNC | SGMO | ||
| Company | Acelyrin Inc | Revance Therapeutics | Sangamo Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.96 | 4.25 | 2.92 | ||
| High | 6.00 | 4.34 | 2.99 | ||
| Low | 5.84 | 3.89 | 2.68 | ||
| Last | 5.94 | 3.89 | 2.86 | ||
| Change | -0.01 | -1.89 | +0.05 | ||
| % Change | -0.17% | -32.70% | +1.78% | ||
| Volume | 24,151 | 4,052,619 | 3,566,381 | ||
| 20-Day Average Volume | 557,283 | 1,706,330 | 13,641,905 | ||
| Previous Close | 5.95 | 5.78 | 2.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.01 | 5.43 | 1.65 | ||
| 20-Day Raw Stochastic | 55.47% | 1.68% | 93.77% | ||
| 20-Day Relative Strength | 55.08% | 30.83% | 78.88% | ||
| Weighted Alpha | -27.95 | -58.11 | +25.16 | ||
| Today's Opinion | 56% Buy | Hold | 100% Buy | ||
| Previous Opinion | 56% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Sell | 24% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.87% since 11/01/24 | -31.28% since 11/01/24 | +51.86% since 11/01/24 | ||
| Low | 5.43 on 11/04/24 | 3.95 on 11/08/24 | 1.72 on 11/05/24 | ||
| High | 6.48 on 11/06/24 | 5.97 on 11/06/24 | 2.99 on 11/08/24 | ||
| 1-Month | |||||
| %Chg | +26.33% since 10/08/24 | -23.64% since 10/08/24 | +253.65% since 10/08/24 | ||
| Low | 4.55 on 10/09/24 | 3.95 on 11/08/24 | 0.77 on 10/10/24 | ||
| High | 6.52 on 10/17/24 | 6.09 on 10/28/24 | 2.99 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | +19.72% since 08/08/24 | +35.12% since 08/08/24 | +211.68% since 08/08/24 | ||
| Low | 3.36 on 08/14/24 | 3.10 on 08/09/24 | 0.70 on 09/09/24 | ||
| High | 6.52 on 10/17/24 | 6.65 on 08/19/24 | 2.99 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +24.22% since 05/08/24 | -6.65% since 05/08/24 | +468.27% since 05/08/24 | ||
| Low | 3.36 on 08/14/24 | 2.30 on 06/26/24 | 0.30 on 07/05/24 | ||
| High | 7.25 on 07/17/24 | 6.65 on 08/19/24 | 2.99 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 593,858 | 605,877 | 585,101 | ||
| Shares Outstanding, K | 99,808 | 104,823 | 208,221 | ||
| Annual Sales | 0 | 234,040,000 | 176,230,000 | ||
| Annual Net Income | -381,640,000 | -323,990,000 | -257,830,000 | ||
| Last Quarter Sales | 0 | 65,390,000 | 360,000 | ||
| Last Quarter Net Income | -85,670,000 | -37,470,000 | -36,130,000 | ||
| 60-Month Beta | 1.98 | 0.95 | 1.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 08/13/24 | -0.37 on 11/07/24 | -0.17 on 08/06/24 | ||
| Latest Earnings Date | 11/13/24 | 11/13/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||